Live AstraZeneca updates

Live AstraZeneca news coverage of developments with the latest updates. Stay on top of latest AstraZeneca news stories and find out what just happened, what is going on with AstraZeneca. The latest real-time news updates and headlines on AstraZeneca
Research Finds Cellular, Genetic Differences in Young-Onset Colorectal Cancer
EU Approves Enhertu for Residual HER2-Positive Early Breast Cancer
Sonesitatug Vedotin Cuts Death Risk 42% in Advanced Gastric Cancer Trial
Tagrisso, Orpathys Cut Progression or Death Risk 45% in Lung Cancer
Imfinzi Plus Imdelltra Cut Death Risk 58% in Lung Cancer Trial
Imfinzi Combo Cuts Bladder Cancer Recurrence Risk 49%, Death Risk 42%
Immunotherapy Combo Extends Survival in Advanced Endometrial Cancer
Ultomiris Wins Accelerated US Approval for IgA Nephropathy Proteinuria
Transparent Minispheres Show Look-Alike Cancer Drugs Differ in 3D
Jacks Tribute To Mum Nets National Stroke Award
Tezspire Shows Promise in Phase III Esophagitis Trial
AstraZeneca, Oracle Launch Global AI Trial Collaboration
AI Facial Scans Help Doctors Assess Age and Survival Risk
AstraZeneca to Present Survival Data From Four Trials at ESMO 2026
AstraZeneca, Insitro Partner on AI-Driven Cardiometabolic Drugs
Beyond Bad Cholesterol: New Clues to Heart Disease Risk
Efzimfotase Alfa Improves Walk Test Results in HPP Trial
Manchester and Cambridge Team Up to Compete Globally
Trump Puts U.S. Industry, Jobs, and Paychecks Back on Map
Research Focuses on Malignant Ascites, Common Cancer Problem
Oxford Launches Phase I Ebola Vaccine Trial in Uganda
AstraZeneca Completes Investment in Summit Therapeutics
AstraZeneca, Daiichi Sankyo, Summit to Test Drug Combination
Triptorelin PBS Listing Restores Certainty for Australian Women
Assistant Minister White Publishes Opinion Piece in Mercury
Imfinzi Combo Gets Priority Review for Muscle-Invasive Bladder Cancer
Cancer Immunotherapy Heightens Severe Infection Risk
Alexion Leads GMG Care With Data at 2026 AANEM, MGFA
EU Approves Trixeo for Asthma Maintenance
AstraZeneca Boosts $100M Youth Health Equity Drive
EU Panel Backs Enhertu for Early HER2+ Breast Cancer
CHMP Backs Klygefa for EU Approval in Treating gMG
Efzimfotase Alfa Gets US Priority Review for HPP Treatment
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
TGA Product Information Safety Updates 11 September
Prioritize Health Over Weight Loss in Obesity Treatment
Cedars-Sinai Unveils Cancer, Brain, Microbiome Insights
New Therapy Cuts COPD Flare-Ups, Trials Show
Imfinzi Combo Boosts Survival in Small Cell Lung Cancer
Tozorakimab Reduces COPD Exacerbations in Phase III Trials
US Approves Etcamah, CDK4/6 Inhibitor for 1st-Line HR+ Breast Cancer
GLP-1 Use Rising Rapidly in US Young Children with Obesity
Anifrolumab Tied to Lower Infection, Hospitalization in Lupus
Anifrolumab Tied to Lower Infection, Hospitalization Risks
AstraZeneca Finalizes Global License for Zegfrovy
EU Approves Enhertu, Pertuzumab for HER2+ Breast Cancer